Healthy Extracts (HYEX) Other financing activities (2018 - 2025)

Healthy Extracts (HYEX) reported Other financing activities of -$64838.0 for Q4 2025, down 283.88% quarter-over-quarter from -$16890.0 in Q1 2022.

Healthy Extracts (HYEX) Other financing activities (2018 - 2025) Analysis & Trends

Healthy Extracts has reported Other financing activities for 3 years, with the latest figure at -$64838.0 in Q4 2025.

For the quarter ending Q4 2025, Other financing activities changed N/A year-over-year to -$64838.0; the trailing twelve-month figure through Dec 2025 stood at -$64838.0 (changed N/A YoY), and the FY2025 full-year result was -$58364.0, changed N/A from the prior year.
Other financing activities for Q4 2025 stood at -$64838.0, down from -$16890.0 in the prior quarter.
The five-year high for Other financing activities was -$16890.0 in Q1 2022, with the low at -$64838.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Healthy Extracts	-	-	957,429.00

Download Data